logoTry Persana

Triomics - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Triomics including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Triomics company logo

Triomics is helping cancer centers reduce manual labor in oncology research and care using Generative AI.

Triomics is helping cancer centers use their health record data with generative AI to reduce manual labor in oncology research and care.

HeadquartersNew York, United States
Team size51-100
FoundedNA

What is Triomics? - Company Overview & Details

Triomics is Triomics is helping cancer centers use their health record data with generative AI to reduce manual labor in oncology research and care., the company is headquartered in New York, United States.

Who Founded Triomics?

Triomics was founded by Sarim Khan, Hrituraj Singh.

Who are the Key Executives at Triomics? - Leadership Team

Triomics is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Triomics

Sarim KhanCEO

Chief Technology Officer (CTO) of Triomics

Hrituraj SinghCTO

About Sarim Khan - CEO of Triomics

Sarim Khan serves as the Chief Executive Officer of Triomics, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Triomics Company Details & Key Information

Where is Triomics located?

Triomics is headquartered in New York, United States.

How many employees does Triomics have?

Triomics has 51-100 employees.

Triomics Official Website

How much funding has Triomics raised?

Triomics has raised $15 million across 3 funding rounds. The most recent funding was completed on 2024-05-09.

Funding Overview

Triomics secured $15 million in Series A funding to automate oncology workflows with generative AI.

$15 million
Total Funding Raised
3
Funding Rounds
2024-05-09
Latest Round

Triomics Funding History

Series A
2024-05-09
$15 million

Who are the key investors in Triomics?

Triomics is backed by 4 key investors including Lightspeed Venture Partners, Nexus Venture Partners, General Catalyst. These investors focus on healthcare, generative AI, technology sectors.

Triomics Investor Overview

4
Key Investors
4
Focus Areas
0
Notable Investments

Complete List of Triomics Investors

Lightspeed Venture Partners

Investment Focus
healthcare
generative AI

Nexus Venture Partners

Investment Focus
healthcare
generative AI

General Catalyst

Investment Focus
healthcare
generative AI

Y Combinator

Investment Focus
technology
education
healthcare

What sectors do Triomics investors focus on?

The investors backing Triomics primarily focus on healthcare, generative AI, technology, education sectors.

healthcare
generative AI
technology
education

Featured Investor: Lightspeed Venture Partners

Lightspeed Venture Partners

Notable Investments:

What are Triomics's future plans?

Triomics Triomics plans to increase its team across domains and scale up the reach of the product.

Triomics Strategic Outlook

Strategic Focus
Defined
3
Key Challenges
2
Growth Opportunities

What challenges does Triomics face?

Triomics has identified 3 key challenges that need to be addressed for continued growth and success.

Key Challenges for Triomics

1

Provider burnout

2

Delays in patient care

3

Backlogs in oncology workflows

What opportunities does Triomics have?

Triomics has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Triomics

1

Expanding partnerships with academic medical centers

2

Increasing customer base in community oncology practices

Triomics Strategic Position Summary

Key Focus Areas

Triomics is addressing 3 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Triomics?

Triomics has 2 recent news updates covering key business developments and market activities.

Triomics News Overview

2
Recent Articles
Active
Media Coverage
2024-05-10
Latest Update

What is Triomics in the news for?

Triomics is currently featured in news for Triomics secures $15M to automate Oncology Workflows with GenAI. and other significant business developments.

Recent News Articles About Triomics

Article 1
2024-05-10

Triomics secures $15M to automate Oncology Workflows with GenAI.

Triomics has raised $15 million to enhance oncology workflows using generative AI.

hitconsultant.net
Read News
Article 2
2024-05-20

Triomics is developing generative AI performance and safety benchmarks and best practices.

Triomics partners with leading cancer centers to establish benchmarks in generative AI for safety and performance.

pulse2.com
Read News

Triomics FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Triomics including information about founders, CEO, funding history, investors, headquarters location, and company details. 18 frequently asked questions covering key information about the company.

Triomics Questions & Answers - Company Information

Q1

What is Triomics?

Triomics is helping cancer centers use their health record data with generative AI to reduce manual labor in oncology research and care.

Q2

Who founded Triomics?

Triomics was founded by Sarim Khan, Hrituraj Singh.

Q3

Who is the CEO of Triomics?

The CEO of Triomics is Sarim Khan. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Triomics raised?

Triomics has raised a total of $$15 million across 3 funding rounds. The most recent funding was completed on 2024-05-09.

Q5

Who are the investors in Triomics?

Triomics's key investors include Lightspeed Venture Partners, Nexus Venture Partners, General Catalyst, Y Combinator.

Q6

Where is Triomics headquartered?

Triomics is headquartered in New York, United States.

Q7

How many employees does Triomics have?

Triomics has 51-100 employees.

Q8

What is Triomics's official website?

You can visit Triomics's official website at https://triomics.com/.

Q9

What was Triomics's latest funding round?

Triomics's latest funding round was a Series A round of $$15 million completed on 2024-05-09.

Q10

Who is founder?

Sarim Khan

Q11

Who is cto?

Hrituraj Singh

Q12

What does the company do?

Triomics helps cancer centers use their health record data with generative AI to reduce manual labor in oncology research and care.

Q13

How much funding?

$15 million

Q14

Latest funding date?

2024-05-09

Q15

Who are the investors?

Lightspeed Venture Partners Nexus Venture Partners General Catalyst Y Combinator

Q16

What are the challenges?

Provider burnout Delays in patient care Backlogs in oncology workflows

Q17

What are the opportunities?

Expanding partnerships with academic medical centers Increasing customer base in community oncology practices

Q18

Latest news?

Triomics has raised $15 million to enhance oncology workflows using generative AI. Triomics partners with leading cancer centers to establish benchmarks in generative AI for safety and performance.

More Information About Triomics

For additional details about Triomics, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.